Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bone Biologics Corp - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
BBLG
Nasdaq
3841
https://www.bonebiologics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bone Biologics Corp
Bone Biologics Announces Closing of $2.0 Million Public Offering
- Mar 6th, 2024 9:15 pm
Bone Biologics Announces Pricing of $2.0 Million Public Offering
- Mar 4th, 2024 2:15 pm
Bone Biologics Reports Progress With NB1 Clinical Program
- Mar 1st, 2024 1:00 pm
BBLG Releases Annual Report Amid Continued Pursuit of Breakthrough Treatment
- Feb 22nd, 2024 11:14 am
Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors
- Jan 11th, 2024 1:00 pm
Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements
- Jan 10th, 2024 1:00 pm
BBLG Announces Split as Pursuit of Breakthrough Treatment Continues
- Dec 20th, 2023 11:10 am
Bone Biologics Announces 1-for-8 Reverse Stock Split
- Dec 18th, 2023 1:00 pm
Bone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- Nov 20th, 2023 5:38 pm
Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- Nov 16th, 2023 9:43 pm
BBLG Offers Good Entry Opportunity
- Nov 15th, 2023 12:03 pm
Bone Biologics Provides Scientific Update on NB1 Bone Graft Device
- Sep 26th, 2023 12:00 pm
Insider Buying: CFO Deina Walsh Acquires 8,000 Shares of Bone Biologics Corp (BBLG)
- Sep 15th, 2023 7:02 am
CEO Jeff Frelick Buys 9,500 Shares of Bone Biologics Corp (BBLG)
- Sep 13th, 2023 9:01 am
BBLG Advances Crucial Technology and Solidifies Funding
- Aug 15th, 2023 12:43 pm
Bone Biologics Prices $5.0 Million Underwritten Public Offering
- Jun 15th, 2023 3:30 am
BBLG: BBLG Advances Crucial Technology and Solidifies Funding
- Jun 8th, 2023 10:15 am
Bone Biologics Effects 1-for-30 Reverse Stock Split
- Jun 6th, 2023 5:00 pm
BBLG: BBLG Has Solid Cash and Is Advancing Testing
- May 16th, 2023 11:20 am
BBLG: Bone Biologics Announces the Approval of A Vital Trial
- Apr 11th, 2023 12:27 pm
Scroll